Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2019: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2017: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Outline of Final Research Achievements |
Autoantibodies (TSAbs) that stimulate the thyroid present in the blood of Graves 'disease patients are responsible for the Graves' disease. Since it is difficult for humans to immediately try a new treatment for Graves' disease, it is necessary to examine it in vitro. Therefore, lymphocytes in the blood of patients with Graves' disease were cultured, and it was examined whether or not TSAb could be detected in the culture medium by a highly sensitive measurement method. An increase in cyclic AMP, which is an index of TSAb, could be confirmed in the culture medium.
|